Evasion of superinfection exclusion and elimination of primary viral RNA by an adapted strain of hepatitis C virus

Journal of Virology

Volumn 87, Issue 24, 2013, Pages 13354-13369

  Webster, Brian ^a   Ott, Melanie ^a,b   Greene, Warner C ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 5A; NONSTRUCTURAL PROTEIN 5B; POLYURIDYLIC ACID; VIRUS RNA;

3' UNTRANSLATED REGION; ALLELIC EXCLUSION; ANTIBODY TITER; ARTICLE; CELL TYPE; CONTROLLED STUDY; DNA BARCODING; GENE E1; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; HEPATITIS C VIRUS; IN VIVO STUDY; INTRASPECIFIC COMPETITION; JC1 GENE; MOLECULAR DYNAMICS; NONHUMAN; P7 GENE; PRIORITY JOURNAL; PROTEIN DOMAIN; REPLICON; REPORTER GENE; RNA REPLICATION; RNA TRANSLATION; SUPERINFECTION; VIRAL CLEARANCE; VIRUS CHARACTERIZATION; VIRUS GENE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS ISOLATION; VIRUS STRAIN;

CELL LINE; HEPACIVIRUS; HEPATITIS C; HUMANS; MUTATION; RNA, VIRAL; SUPERINFECTION; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 84888054988     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02465-13     Document Type: Article

References (53)

1. Michel N, Allespach I, Venzke S, Fackler OT, Keppler OT. 2005. The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell surface CCR5 and CD4. Curr. Biol. 15:714-723.
2. Adams RH, Brown DT. 1985. BHK cells expressing Sindbis virus-induced homologous interference allow the translation of nonstructural genes of superinfecting virus. J. Virol. 54:351-357.
3. Walters KA, Joyce MA, Addison WR, Fischer KP, Tyrrell DL. 2004. Superinfection exclusion in duck hepatitis B virus infection is mediated by the large surface antigen. J. Virol. 78:7925-7937.
4. Folimonova SY. 2012. Superinfection exclusion is an active viruscontrolled function that requires a specific viral protein. J. Virol. 86:5554-5561.
5. Schaller T, Appel N, Koutsoudakis G, Kallis S, Lohmann V, Pietschmann T, Bartenschlager R. 2007. Analysis of hepatitis C virus superinfection exclusion by using novel fluorochrome gene-tagged viral genomes. J. Virol. 81:4591-4603.
6. Tscherne DM, Evans MJ, von Hahn T, Jones CT, Stamataki Z, McKeating JA, Lindenbach BD, Rice CM. 2007. Superinfection exclusion in cells infected with hepatitis C virus. J. Virol. 81:3693-3703.
7. Evans MJ, Rice CM, Goff SP. 2004. Genetic interactions between hepatitis C virus replicons. J. Virol. 78:12085-12089.
8. Lee YM, Tscherne DM, Yun SI, Frolov I, Rice CM. 2005. Dual mechanisms of pestiviral superinfection exclusion at entry and RNA replication. J. Virol. 79:3231-3242.
9. Pietschmann T, Kaul A, Koutsoudakis G, Shavinskaya A, Kallis S, Steinmann E, Abid K, Negro F, Dreux M, Cosset FL, Bartenschlager R. 2006. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. U.S.A. 103:7408-7413.
10. Dorner M, Horwitz JA, Donovan BM, Labitt RN, Budell WC, Friling T, Vogt A, Catanese MT, Satoh T, Kawai T, Akira S, Law M, Rice CM, Ploss A. 2013. Completion of the entire hepatitis C virus life cycle in genetically humanized mice. Nature 501:237-241.
11. Horwitz JA, Dorner M, Friling T, Donovan BM, Vogt A, Loureiro J, Oh T, Rice CM, Ploss A. 2013. Expression of heterologous proteins flanked by NS3-4A cleavage sites within the hepatitisCvirus polyprotein. Virology 439:23-33.
12. Vogt A, Scull MA, Friling T, Horwitz JA, Donovan BM, Dorner M, Gerold G, Labitt RN, Rice CM, Ploss A. 2013. Recapitulation of the hepatitis C virus life-cycle in engineered murine cell lines. Virology 444:1-11.
13. Blight KJ, McKeating JA, Rice CM. 2002. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76:13001-13014.
14. Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
15. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, Zhao Z, Murthy K, Habermann A, Krausslich HG, Mizokami M, Bartenschlager R, Liang TJ. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796.
16. Kato T, Date T, Murayama A, Morikawa K, Akazawa D, Wakita T. 2006. Cell culture and infection system for hepatitis C virus. Nat. Protoc. 1:2334-2339.
17. Webster B, Wissing S, Herker E, Ott M, Greene WC. 2013. Rapid intracellular competition between hepatitis C viral genomes as a result of mitosis. J. Virol. 87:581-596.
18. Boson B, Granio O, Bartenschlager R, Cosset FL. 2011. A concerted action of hepatitis C virus p7 and nonstructural protein 2 regulates core localization at the endoplasmic reticulum and virus assembly. PLoS Pathog. 7:e1002144. doi:10.1371/journal.ppat.1002144.
19. Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV. 2005. Robust hepatitis C virus infection in vitro. Proc. Natl. Acad. Sci. U.S.A. 102:9294-9299.
20. Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, Pietschmann T, Bartenschlager R. 2006. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J. Virol. 80:5308-5320.
21. Gottwein JM, Jensen TB, Mathiesen CK, Meuleman P, Serre SB, Lademann JB, Ghanem L, Scheel TK, Leroux-Roels G, Bukh J. 2011. Development and application of hepatitis C reporter viruses with genotype 1 to 7 core-nonstructural protein 2 (NS2) expressing fluorescent proteins or luciferase in modified JFH1 NS5A. J. Virol. 85:8913-8928.
22. Jones CT, Murray CL, Eastman DK, Tassello J, Rice CM. 2007. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J. Virol. 81:8374-8383.
23. Murray CL. 2007. Genetic and biochemical analyses of the flaviviridae capsid proteins. Ph.D. thesis. Rockefeller University, New York, NY.
24. Timpe JM, Stamataki Z, Jennings A, Hu K, Farquhar MJ, Harris HJ, Schwarz A, Desombere I, Roels GL, Balfe P, McKeating JA. 2008. HepatitisCvirus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology 47:17-24.
25. Hazari S, Chandra PK, Poat B, Datta S, Garry RF, Foster TP, Kousoulas G, Wakita T, Dash S. 2010. Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway. Virol. J. 7:36.
26. Cheng G, Chan K, Yang H, Corsa A, Pokrovskii M, Paulson M, Bahador G, Zhong W, Wt Delaney. 2011. Selection of clinically relevant protease inhibitor-resistant viruses using the genotype 2a hepatitis C virus infection system. Antimicrob. Agents Chemother. 55:2197-2205.
27. Fournier C, Helle F, Descamps V, Morel V, Francois C, Dedeurwaerder S, Wychowski C, Duverlie G, Castelain S. 2013. Natural selection of adaptive mutations in nonstructural genes increases trans-encapsidation of hepatitis C virus replicons lacking envelope protein genes. J. Gen. Virol. 94:996-1008.
28. Kolykhalov AA, Agapov EV, Rice CM. 1994. Specificity of the hepatitis C virus NS3 serine protease:effects of substitutions at the 3/4A, 4A/4B, 4B/ 5A, and 5A/5B cleavage sites on polyprotein processing. J. Virol. 68:7525-7533.
29. Choi J, Lee KJ, Zheng Y, Yamaga AK, Lai MM, Ou JH. 2004. Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells. Hepatology 39:81-89.
30. Garcia-Rivera JA, Lin K, Hopkins S, Gregory MA, Wilkinson B, Gallay PA. 2012. Development of a flow cytometry live cell assay for the screening of inhibitors of hepatitis C virus (HCV) replication. Open Virol. J. 6:97-102.
31. Lauring AS, Andino R. 2011. Exploring the fitness landscape of an RNA virus by using a universal barcode microarray. J. Virol. 85:3780-3791.
32. White MJ, Fristensky BW, Thompson WF. 1991. Concatemer chain reaction:a Taq DNA polymerase-mediated mechanism for generating long tandemly repetitive DNA sequences. Anal. Biochem. 199:184-190.
33. Witteveldt J, Evans MJ, Bitzegeio J, Koutsoudakis G, Owsianka AM, Angus AG, Keck ZY, Foung SK, Pietschmann T, Rice CM, Patel AH. 2009. CD81 is dispensable for hepatitis C virus cell-to-cell transmission in hepatoma cells. J. Gen. Virol. 90:48-58.
34. Lohmann V, Hoffmann S, Herian U, Penin F, Bartenschlager R. 2003. Viral and cellular determinants of hepatitis C virus RNA replication in cell culture. J. Virol. 77:3007-3019.
35. Li YP, Ramirez S, Gottwein JM, Scheel TK, Mikkelsen L, Purcell RH, Bukh J. 2012. Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains. Proc. Natl. Acad. Sci. U.S.A. 109:E1101-E1110.
36. Murayama A, Weng L, Date T, Akazawa D, Tian X, Suzuki T, Kato T, Tanaka Y, Mizokami M, Wakita T, Toyoda T. 2010. RNA polymerase activity and specific RNA structure are required for efficient HCV replication in cultured cells. PLoS Pathog. 6:e1000885. doi:10.1371/journal.ppat.1000885.
37. Tardif KD, Mori K, Siddiqui A. 2002. Hepatitis C virus subgenomic replicons induce endoplasmic reticulum stress activating an intracellular signaling pathway. J. Virol. 76:7453-7459.
38. Krieger N, Lohmann V, Bartenschlager R. 2001. Enhancement of hepatitis C virus RNA replication by cell culture-adaptive mutations. J. Virol. 75:4614-4624.
39. Han TX, Xu XY, Zhang MJ, Peng X, Du LL. 2010. Global fitness profiling of fission yeast deletion strains by barcode sequencing. Genome Biol. 11:R60.
40. Smith AM, Heisler LE, Mellor J, Kaper F, Thompson MJ, Chee M, Roth FP, Giaever G, Nislow C. 2009. Quantitative phenotyping via deep barcode sequencing. Genome Res. 19:1836-1842.
41. Tuteja R, Tuteja N. 2004. Serial analysis of gene expression (SAGE):unraveling the bioinformatics tools. Bioessays 26:916-922.
42. Smith AM, Durbic T, Oh J, Urbanus M, Proctor M, Heisler LE, Giaever G, Nislow C. 2011. Competitive genomic screens of barcoded yeast libraries. J. Vis. Exp. 54:pii=2864. doi:10.3791/2864.
43. Miyamoto M, Kato T, Date T, Mizokami M, Wakita T. 2006. Comparison between subgenomic replicons of hepatitis C virus genotypes 2a (JFH-1) and 1b (Con1 NK5.1). Intervirology 49:37-43.
44. Binder M, Quinkert D, Bochkarova O, Klein R, Kezmic N, Bartenschlager R, Lohmann V. 2007. Identification of determinants involved in initiation of hepatitis C virus RNA synthesis by using intergenotypic replicase chimeras. J. Virol. 81:5270-5283.
45. Liu S, Yang W, Shen L, Turner JR, Coyne CB, Wang T. 2009. Tight junction proteins claudin-1 and occludin control hepatitis C virus entry and are downregulated during infection to prevent superinfection. J. Virol. 83:2011-2014.
46. Nakamuta M, Fujino T, Yada R, Aoyagi Y, Yasutake K, Kohjima M, Fukuizumi K, Yoshimoto T, Harada N, Yada M, Kato M, Kotoh K, Taketomi A, Maehara Y, Nakashima M, Enjoji M. 2011. Expression profiles of genes associated with viral entry in HCV-infected human liver. J. Med. Virol. 83:921-927.
47. Reynolds GM, Harris HJ, Jennings A, Hu K, Grove J, Lalor PF, Adams DH, Balfe P, Hubscher SG, McKeating JA. 2008. Hepatitis C virus receptor expression in normal and diseased liver tissue. Hepatology 47:418-427.
48. Sainz B, Jr, Barretto N, Martin DN, Hiraga N, Imamura M, Hussain S, Marsh KA, Yu X, Chayama K, Alrefai WA, Uprichard SL. 2012. Identification of the Niemann-Pick C1-like 1 cholesterol absorption receptor as a new hepatitis C virus entry factor. Nat. Med. 18:281-285.
49. Wang H, Shen XT, Ye R, Lan SY, Xiang L, Yuan ZH. 2005. Roles of the polypyrimidine tract and 3' noncoding region of hepatitis C virus RNA in the internal ribosome entry site-mediated translation. Arch. Virol. 150:1085-1099.
50. Scheel TK, Gottwein JM, Jensen TB, Prentoe JC, Hoegh AM, Alter HJ, Eugen-Olsen J, Bukh J. 2008. Development of JFH1-based cell culture systems for hepatitis C virus genotype 4a and evidence for cross-genotype neutralization. Proc. Natl. Acad. Sci. U.S.A. 105:997-1002.
51. Gottwein JM, Scheel TK, Jensen TB, Lademann JB, Prentoe JC, Knudsen ML, Hoegh AM, Bukh J. 2009. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems:role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49:364-377.
52. Liu S, Xiao L, Nelson C, Hagedorn CH. 2012. A cell culture adapted HCVJFH1 variant that increases virus titers and permits the production of high titer infectious chimeric reporter viruses. PLoS One 7:e44965. doi:10.1371/journal.pone.0044965.
53. Ramirez S, Perez-del-Pulgar S, Carrion JA, Coto-Llerena M, Mensa L, Dragun J, Garcia-Valdecasas JC, Navasa M, Forns X. 2010. Hepatitis C virus superinfection of liver grafts:a detailed analysis of early exclusion of non-dominant virus strains. J. Gen. Virol. 91:1183-1188.